Photodynamic Therapy Market by Type (Porphyrins, Porphyrazines, Chlorins, Other), By Application (Cancer Treatment, Dermatology, Ophthalmology, Infectious Diseases, Other), By End-user (Hospitals and Clinics, Dermatology Clinics, Ophthalmology Centers, Ambulatory Surgical Centers, Research Institutes), Global Market Size, Segmental analysis, Regional Overview, Company shares analysis, Leading Company Profiles and Market Forecast, 2025 – 2035

Published Date: Feb 2025 | Report ID: MI1930 | 215 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

Report Coverage:

By Type

  • Porphyrins
  • Porphyrazines
  • Chlorins
  • Other

By Application

  • Cancer Treatment
  • Dermatology
  • Ophthalmology
  • Infectious Diseases
  • Other

By End-user

  • Hospitals and Clinics
  • Dermatology Clinics
  • Ophthalmology Centers
  • Ambulatory Surgical Centers
  • Research Institutes

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies:

  • Pfizer
  • Novartis
  • Roche
  • Teva Pharmaceutical Industries
  • DUSA Pharmaceuticals
  • Biofrontera AG
  • Galderma
  • Misonix
  • Merck & Co.
  • Akorn
  • Photocure
  • Curadigm
  • OncoOne
  • Sigma-Aldrich (Merck Group)
  • Lumicell

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing